Life Science Innovation Central to Next Decade of Investment Opportunities
Over the next 10 years, we are most excited about investment opportunities in innovative life science companies, explains Sands Capital Management’s Chief Executive and Chief Investment Officer Frank Sands speaking before the Pensions & Investment’s Private Market Virtual Series, he credited the dramatic decrease in the cost of gene sequencing for enabling improvements in diagnostics, therapeutics, and medical devices that are improving patient outcomes and generating wealth creation opportunities for long-term investors.
References to companies presented for illustrative purposes only. Uber is a current holding in Select Growth and Global Growth. AirBNB is a current holding in Select Growth and Technology Innovators. DoorDash is a current holding in Select Growth, Global Growth and Technology Innovators.
The views expressed are the opinion of Sands Capital Management and are not intended as a forecast, a guarantee of future results, investment recommendations, or an offer to buy or sell any securities. The views expressed were current as of 6/17/2021 and are subject to change. This material may contain forward-looking statements, which are subject to uncertainty and contingencies outside of Sands Capital’s control. Readers should not place undue reliance upon these forward-looking statements. There is no guarantee that Sands Capital will meet its stated goals. Past performance is not indicative of future results. The specific securities identified and described do not represent all of the securities purchased, sold, or recommended for advisory clients. There is no assurance that any securities discussed will remain in the portfolio or that securities sold have not been repurchased. You should not assume that any investment is or will be profitable. PT 20210121